A variety of acquired disorders cause chorea, such as hypoxia-ischemia injury, drugs, toxins, infections, autoimmune disorders, and endocrine and electrolyte abnormalities, but rarely subdural hematoma. We report the case of a 76-year-old woman who presented with sudden onset of generalized choreiform movements 1 day prior to admission. Computed tomography revealed a bilateral lateral convexity subdural effusion, which was later confirmed by magnetic resonance imaging as a chronic subdural hematoma. After surgical evacuation of the subdural hematoma, the choreoathetoid movements ceased completely. We propose that transient ischemia in the bilateral subcortical regions was from compression and distortion of the brain by the bilateral hematomas and resulted in generalized chorea.

1.
Janavs JL, Aminoff MJ: Dystonia and chorea in acquired systemic disorders. J Neurol Neurosurg Psychiatry 1998;65:436–445.
2.
Burnett L, Jankovic J: Chorea and ballism. Curr Opin Neurol Neurosurg 1992;5:308–313.
3.
Kase CS, Maulsby GO, DeJuan E, Mohr JP: Hemichorea-hemiballism and lacunar infarction in the basal ganglia. Neurology 1981;31:452–455.
4.
Srinivas K, Rao VM, Subbulakshmi N, Bhaskaran J: Hemiballism after striatal hemorrhage. Neurology 1987;37:1428–1429.
5.
Saris S: Chorea caused by caudate infarction. Arch Neurol 1983;40:590–591.
6.
Tabaton M, Mancardi G, Loeb C: Generalized chorea due to bilateral small, deep cerebral infarcts. Neurology 1985;35:588–589.
7.
Linazasoro G, Urtasun M, Poza JJ, Suarez JA, Marti Masso JF: Generalized chorea induced by nonketotic hyperglycemia. Mov Disord 1993;8:119–120.
8.
Lin JJ, Lin GY, Shih C, Shen WC: Presentation of striatal hyperintensity on T1-weighted MRI in patients with hemiballism-hemichorea caused by non-ketotic hyperglycemia: Report of seven new cases and a review of literature. J Neurol 2001;248:750–755.
9.
Shoulson I: On chorea. Clin Neuropharmacol 1986;9(suppl 2):S85–S99.
10.
Garcia-Ruiz PJ, Garcia de Yebenes J, Jimenez-Jimenez FJ, Vazquez A, Garcia Urra D, Morales B: Parkinsonism associated with calcium channel blockers: A prospective follow-up study. Clin Neuropharmacol 1992;15:19–26.
11.
Daniel JR, Mauro VF: Extrapyramidal symptoms associated with calcium-channel blockers. Ann Pharmacother 1995;29:73–75.
12.
Bean SC, Ladisch S: Chorea associated with a subdural hematoma in a child with leukemia. J Pediatr 1977;90:255–256.
13.
Gilmore PC, Brenner RP: Chorea: A late complication of a subdural hematoma. Neurology 1979;29:1044–1045.
14.
Bae SH, Vates TS Jr, Kenton EJ 3rd: Generalized chorea associated with chronic subdural hematomas. Ann Neurol 1980;8:449–450.
15.
Vincent FM: Chorea: A late complication of a subdural hematoma (letter). Neurology 1980;30:335–336.
16.
Yoshikawa M, Yamamoto M, Shibata K, Ohta K, Kamite Y, Takahashi M, Shimizu Y, Ohba S, Kuwabara S, Uozumi T: Hemichorea associated with ipsilateral chronic subdural hematoma – Case report. Neurol Med Chir (Tokyo) 1992;32:769–772.
17.
Hosokawa S, Ichiya Y, Kuwabara Y, Ayabe Z, Mitsuo K, Goto I, Kato M: Positron emission tomography in cases of chorea with different underlying diseases. J Neurol Neurosurg Psychiatry 1987;50:1284–1287.
18.
Dilenge ME, Shevell MI, Dinh L: Restricted unilateral Sydenham’s chorea: Reversible contralateral striatal hypermetabolism demonstrated on single photon emission computed tomographic scanning. J Child Neurol 1999;14:509–513.
19.
Pudenz RH, Foltz EL: Hydrocephalus: Overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 1991;35:200–212.
20.
Samuelson S, Long DM, Chou SN: Subdural hematoma as a complication of shunting procedures for normal pressure hydrocephalus. J Neurosurg 1972;37:548–551.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.